{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:06:30Z","timestamp":1773957990266,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2009,4,21]],"date-time":"2009-04-21T00:00:00Z","timestamp":1240272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1000049","type":"journal-article","created":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T22:01:54Z","timestamp":1240264914000},"page":"e1000049","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":152,"title":["Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets"],"prefix":"10.1371","volume":"6","author":[{"given":"Surender","family":"Khurana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amorsolo L.","family":"Suguitan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonaira","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron P.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lanzavecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanta","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2009,4,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses.","volume":"7","author":"K Subbarao","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(08)60627-3","article-title":"Human infection with highly pathogenic H5N1 influenza virus.","volume":"371","author":"A Gambotto","year":"2008","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1371\/journal.pmed.0040178","article-title":"Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.","volume":"4","author":"CP Simmons","year":"2007","journal-title":"PLoS Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies.","volume":"105","author":"AK Kashyap","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"TC Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection.","volume":"357","author":"B Zhou","year":"2007","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0609330104","article-title":"Ab and T cell epitopes of influenza A virus, knowledge and opportunities.","volume":"104","author":"HH Bui","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.","volume":"12","author":"MD de Jong","year":"2006","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.qai.0000242465.50947.5f","article-title":"Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.","volume":"43","author":"S Khurana","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine.","volume":"103","author":"I Stephenson","year":"2004","journal-title":"Virus Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.","volume":"37","author":"T Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza A\/H3N2 viruses: an international collaborative study.","volume":"25","author":"I Stephenson","year":"2007","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection.","volume":"353","author":"MD de Jong","year":"2005","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1128\/JVI.79.11.6791-6800.2005","article-title":"Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.","volume":"79","author":"S Khurana","year":"2005","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.","volume":"289","author":"DC Wiley","year":"1981","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.173.4.953","article-title":"Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA\/Ca mice to influenza hemagglutinin.","volume":"173","author":"CA Smith","year":"1991","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.","volume":"443","author":"RJ Russell","year":"2006","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3201\/eid1204.051020","article-title":"Prospects for universal influenza virus vaccine.","volume":"12","author":"W Gerhard","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1371\/journal.ppat.0030141","article-title":"A single mutation in the PB1-F2 of H5N1 (HK\/97) and 1918 influenza A viruses contributes to increased virulence.","volume":"3","author":"GM Conenello","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/JVI.80.5.2092-2099.2006","article-title":"Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.","volume":"80","author":"S Khurana","year":"2006","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/376092a0","article-title":"Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.","volume":"376","author":"T Bizebard","year":"1995","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.","volume":"289","author":"IA Wilson","year":"1981","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(82)90202-1","article-title":"Immunogenic structure of the influenza virus hemagglutinin.","volume":"28","author":"N Green","year":"1982","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1128\/JVI.01522-07","article-title":"Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.","volume":"81","author":"NV Kaverin","year":"2007","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1099\/0022-1317-83-10-2497","article-title":"Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants.","volume":"83","author":"NV Kaverin","year":"2002","journal-title":"J Gen Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.virol.2006.03.048","article-title":"Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam.","volume":"350","author":"GJ Smith","year":"2006","journal-title":"Virology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.","volume":"3","author":"M Throsby","year":"2008","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virusres.2007.10.004","article-title":"HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.","volume":"132","author":"E Vareckova","year":"2008","journal-title":"Virus Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.","volume":"4","author":"MR Sandbulte","year":"2007","journal-title":"PLoS Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice.","volume":"64","author":"JJ Treanor","year":"1990","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein.","volume":"5","author":"S Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.","volume":"22","author":"J Fan","year":"2004","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.","volume":"13","author":"SM Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref34","first-page":"218","article-title":"Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.","volume":"385","author":"TM Fu","year":"2008","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/0022-1317-74-1-143","article-title":"Antibody response to the M2 protein of influenza A virus expressed in insect cells.","volume":"74 (Pt 1)","author":"RA Black","year":"1993","journal-title":"J Gen Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1128\/JVI.00415-06","article-title":"Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.","volume":"80","author":"D Zamarin","year":"2006","journal-title":"J Virol"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1000049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:37:42Z","timestamp":1589733462000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1000049"}},"subtitle":[],"editor":[{"given":"Malik","family":"Peiris","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,21]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1000049","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,21]]}}}